Background: Prophylaxis may be considered for frequent acute attacks of hereditary angioedema (HAE); moreover, prophylaxis efficacy may impact direct costs associated with medical utilization/medication.
Objectives:To present data on the efficacy and cost savings of investigational prophylactic treatment with recombinant human C1-esterase inhibitor (rhC1-INH).Methods: Retrospective chart review of patient with HAE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.